Clinical Trial Update: Safety and Efficacy Study of 0.5%, 0.1% & 0.01% Atropine Treatment to Both Eyes In Treatment of Myopia In Children [Phase 2, Phase 3]

View source ↗

Summary

This document describes a safety and efficacy study of atropine eye drops (0.5%, 0.1%, and 0.01%) in both eyes for treating myopia in children, conducted in Pha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopia

Drugs mentioned

• Atropine (atropine)

Snippet

Sponsor: Singapore National Eye Centre | Conditions: Myopia | Phase 2, Phase 3 | Status: UNKNOWN